SERP1 and pancreatic neoplasm: A time course study further confirmed inhibition of Hs766t pancreatic cancer growth by 4-weeks with Serp-1 treatment (P< 0.02), but without significant inhibition at earlier follow-up times (Figure 1D; P<0.02 at 4 weeks).